CD4CAR
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CD4CAR, covering 2026-01-22 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML. [Phase 1]